Abstract
A 63-year-old woman received zoledronic acid for the treatment of skeletal metastases from medullary carcinoma of the breast. A day later, she developed pain and swelling in the left eye. The diagnosis of left eye sclerokeratouveitis was made by external examination, slit lamp, and fundus examination, supported by optical coherence tomography (OCT) and B-scan findings. Zoledronic acid was discontinued. The patient was treated with oral steroids and topical steroids. On follow-up, there was complete resolution of sclerokeratouveitis in the left eye. The periocular and ocular inflammation caused by bisphosphonates can be successfully treated with systemic and topical steroids along with the discontinuation of the inciting drug. This is the first reported case of zoledronate-induced ocular inflammation with intraocular imaging findings. Oncologists and ophthalmologists should be aware of this side effect of zoledronic acid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
